The promise is real, but clinical readiness is not: Preclinical and early human data are compelling, but without large-scale trials, validated delivery methods, and long-term safety data, Epitalon remains an experimental peptide, one to watch closely, but not yet ready for mainstream clinical adoption
A phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCGrefractory and BCG-intolerant patients
Therefore, oftentimes supplementation is sought after in those disease states
Neck pain presents itself in different forms depending on the individual and the underlying cause
Weeks 5-8, Weeks 9-12, Weeks 13-16 2 vials Weeks 5-8: About 10.5 mg used at 375 mcg/day
How the amount and/or activity of these proteins are regulated under various conditions though, needs to be further determined